Real-World Effectiveness and Safety of Direct-Acting Antivirals in Patients with Chronic Hepatitis C and Epilepsy: An Epi-Ter-2 Study in Poland

Introduction: In Poland, active HCV infection affects between 0.4 and 0.5% of the population, i.e., about 150,000 people, while the number of patients with epilepsy is estimated to be 350,000–400,000. Currently available antiviral therapies show little interaction with neurological drugs. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pazgan-Simon, Monika, Jaroszewicz, Jerzy, Simon, Krzysztof, Lorenc, Beata, Sitko, Marek, Zarębska-Michaluk, Dorota, Dybowska, Dorota, Tudrujek-Zdunek, Magdalena, Berak, Hanna, Mazur, Włodzimierz, Klapaczyński, Jakub, Janczewska, Ewa, Parfieniuk-Kowerda, Anna, Flisiak, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381851/
https://www.ncbi.nlm.nih.gov/pubmed/37511724
http://dx.doi.org/10.3390/jpm13071111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381851/
https://www.ncbi.nlm.nih.gov/pubmed/37511724
http://dx.doi.org/10.3390/jpm13071111

Ejemplares similares